Why EverydayMeds Offers Unbeatable Value for Both Treatments
Wegovy vs Mounjaro: Understanding the UK Price Landscape
The UK market for prescription weight management treatments has become increasingly competitive, but finding genuine value requires looking beyond headline prices. When comparing Wegovy vs Mounjaro costs, many providers add hidden consultation fees, delivery charges, or require expensive membership schemes. EverydayMeds takes a different approach – our transparent pricing includes everything: clinical assessment, prescriber review, the prescription-only medicine itself, and next-day cold-chain delivery.
Wegovy pricing starts at £79.99 for the essential 0.25mg starter dose, progressing through a carefully structured dose escalation schedule to the 2.4mg maintenance dose at £209.99. Mounjaro follows a similar pricing structure but with different dose increments reflecting its unique tirzepatide formulation. Both treatments require the same rigorous clinical oversight, making our all-inclusive pricing model particularly valuable for patients beginning their weight management journey with either option.
Complete Wegovy vs Mounjaro Pricing Breakdown
Understanding the full cost commitment is crucial when choosing between Wegovy vs Mounjaro. Wegovy's dose escalation follows a proven pathway: 0.25mg (£79.99), 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), and 2.4mg maintenance (£209.99). Our Getting Started bundles offer convenience for the escalation phase – the Intro Trio containing 0.25mg, 0.5mg and 1mg doses costs £299.99, providing your first three months of treatment with Reliable Supply continuity.
For patients requiring extended maintenance therapy, our Ultimate Stability Trio provides three months of 2.4mg Wegovy doses for £649.99 – a practical solution for long-term weight management. Discount codes FIRST40 (new customers) and DOSE25 (returning customers) are applied at checkout to reach these final prices. Mounjaro pricing follows similar principles but reflects the different titration schedule required for tirzepatide, ensuring both options remain accessible through our competitive pricing structure.
Clinical Evidence: Wegovy vs Mounjaro Treatment Approaches
Both Wegovy and Mounjaro have demonstrated significant efficacy in clinical trials, though their mechanisms differ substantially. In the STEP trials, patients taking Wegovy alongside diet and exercise achieved an average weight loss of approximately 15% at 68 weeks compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The STEP SELECT trial also demonstrated a 20% reduction in major cardiovascular events, highlighting Wegovy's broader health benefits beyond weight management.
Mounjaro's SURMOUNT trial programme has shown comparable efficacy using its dual-hormone approach targeting both GIP and GLP-1 receptors. When comparing Wegovy vs Mounjaro, it's important to note that these trials used different methodologies and patient populations, making direct comparisons inappropriate. Both treatments are prescription-only medicines requiring careful clinical assessment to determine suitability for individual patients.
How Wegovy Works: GLP-1 Mechanism Explained
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics a natural fullness hormone produced in your intestines. This hormone normally signals to your brain when you've eaten enough, but in people with obesity, this signalling system often becomes less effective. Wegovy enhances these natural satiety signals, helping you feel satisfied with smaller portions and reducing food cravings between meals. The medication works on specific appetite centres in the brain, particularly the hypothalamus, which regulates hunger and energy balance. Unlike stimulant-based appetite suppressants, Wegovy's mechanism feels natural because it's amplifying your body's existing fullness signals rather than artificially suppressing appetite.
Streamlined Ordering Process for Both Treatments
Whether you choose Wegovy or Mounjaro, our ordering process remains consistently straightforward and clinically robust. The journey begins with our comprehensive 3-minute online clinical assessment, designed to capture all relevant medical history, current medications, and weight management goals. This information is reviewed by our qualified prescribers who can determine whether Wegovy's GLP-1 approach or Mounjaro's dual-hormone mechanism is more appropriate for your circumstances. Standard prescriber review takes three working days, though express 24-hour review is available for urgent cases. Once approved, your prescription-only medicine is dispatched via next-day cold-chain delivery with full temperature monitoring to ensure optimal product integrity. Our GPhC-registered pharmacy (#9012878) maintains the highest standards for controlled temperature storage and delivery logistics.
Storage and Practical Considerations: Wegovy vs Mounjaro
Storage requirements can significantly impact daily life with either treatment, making this an important factor when comparing Wegovy vs Mounjaro. Wegovy offers a distinct advantage here – once removed from refrigeration, it can be stored at room temperature (below 30°C) for up to 6 weeks, compared to Mounjaro's 21-day limit. This makes Wegovy particularly suitable for frequent travellers or those with unpredictable schedules. Both medications require refrigerated storage at 2-8°C before first use and utilise similar pre-filled injection pen systems. The FlexTouch pen used for Wegovy is particularly user-friendly, with clear dose indicators and an intuitive injection mechanism. Dose escalation is mandatory for both treatments – you cannot skip steps in the titration schedule as this increases the risk of gastrointestinal side effects that may impact treatment adherence.
Value Proposition: Why Choose EverydayMeds for Wegovy vs Mounjaro
When evaluating providers for either Wegovy or Mounjaro, the total cost of care extends beyond the medication price. Many clinics charge separate consultation fees, require expensive membership programmes, or add delivery surcharges that can double the advertised price. EverydayMeds includes all essential services in our transparent pricing – no hidden extras or recurring subscription fees.
Our clinical team's expertise in both treatments means you receive genuinely personalised guidance rather than pressure to choose the more expensive option. Whether Wegovy's proven GLP-1 mechanism or Mounjaro's innovative dual-hormone approach is more suitable depends on your individual circumstances, medical history, and treatment goals. This decision should be made based on clinical factors, not pricing pressure from providers with financial incentives to promote particular treatments.
Making Your Decision: Wegovy vs Mounjaro Final Considerations
The choice between Wegovy and Mounjaro ultimately depends on individual factors that our prescribers can help evaluate during your clinical assessment. Wegovy's longer room temperature storage, established cardiovascular benefits, and proven long-term efficacy data make it suitable for many patients beginning weight management treatment. Mounjaro's dual-hormone mechanism may offer advantages for patients with specific metabolic profiles or those who haven't responded optimally to single-hormone approaches. Both treatments require commitment to lifestyle changes including reduced-calorie diet and increased physical activity – the medication supports these efforts rather than replacing them. Your prescriber will consider factors including your medical history, current medications, lifestyle requirements, and personal preferences when recommending the most appropriate option. Both Wegovy and Mounjaro are available from EverydayMeds – your prescriber can help determine which is right for you, ensuring you receive the most suitable treatment at the UK's best prices.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
